Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

1,010.70INR
30 Mar 2015
Change (% chg)

-- (--)
Prev Close
Rs1,010.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
214,490
52-wk High
Rs1,074.05
52-wk Low
Rs566.00

SUN.BO

Chart for SUN.BO

About

Sun Pharmaceutical Industries Ltd. (Sun) is a specialty pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations as branded generics, as well as generics, in the United States, India and other markets. It operates through four segments: US Generics, Indian Branded Generics, Internationa... (more)

Overall

Beta: 0.51
Market Cap(Mil.): Rs2,094,361.00
Shares Outstanding(Mil.): 2,071.16
Dividend: 1.50
Yield (%): 0.15

Financials

  SUN.BO Industry Sector
P/E (TTM): 35.32 40.31 40.78
EPS (TTM): 28.63 -- --
ROI: -- 16.86 16.19
ROE: -- 17.40 17.04
Search Stocks

Sun Pharma open to large acquisitions post Ranbaxy

MUMBAI - India's largest drugmaker Sun Pharmaceutical Industries Ltd will look at making more large acquisitions even as it winds up a $3.2 billion deal to buy smaller rival Ranbaxy Laboratories Ltd.

25 Mar 2015

BUZZ-Investors take tactical refuge in Indian pharma ahead of Fed

** Pharmaceutical stocks, traditionally seen as defensives, gain on churning ahead of the U.S. Federal Reserve policy meeting outcome on Wednesday

17 Mar 2015

Sensex edges up; consumer and healthcare stocks rise

MUMBAI - The BSE Sensex and Nifty edged up on Thursday in a volatile session as consumer and healthcare stocks such as Sun Pharmaceutical Industries rose with investors favouring defensive bets, though losses in telecoms and banks capped gains.

05 Mar 2015

Indian shares edge up; consumer and healthcare stocks rise

MUMBAI, March 5 - Indian shares edged up on Thursday in a volatile session as consumer and healthcare stocks such as Sun Pharmaceutical Industries rose with investors favouring defensive bets, though losses in telecoms and banks capped gains.

05 Mar 2015

Sun Pharma to buy Glaxo's opiates business in Australia

MUMBAI - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.

03 Mar 2015

CORRECTED-BUZZ-India's Suzlon rises to daily upper limit on turnaround hopes

** Suzlon Energy shares jump as much as 20 pct to daily upper limit

18 Feb 2015

Sun Pharma third-quarter profit falls

MUMBAI - Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Saturday third-quarter net profit fell unexpectedly due to a decline in sales in the United States and costs from resolving regulatory issues at a manufacturing plant.

14 Feb 2015

BUZZ-India's Suzlon gains on talk of investment by Sun Pharma founder

** Traders cite persistent speculation that billionaire and Sun Pharmaceutical Industries Ltd's founder Dilip Shanghvi is looking to invest in the company in a personal capacity

12 Feb 2015

Deals of the day- Mergers and acquisitions

Jan 30 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:

31 Jan 2015

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

31 Jan 2015

Earnings vs. Estimates

Search Stocks